Skip to main content
. Author manuscript; available in PMC: 2022 Jun 29.
Published in final edited form as: Cancer. 2020 Dec 10;127(7):1049–1056. doi: 10.1002/cncr.33325

TABLE 4.

Summary of the Final Logistic Regression Model Predicting Q4 Status

Predictor and Control Variables No. Adjusted Odds Ratio 95% CI P
Predictor variables
 Change in No. of implemented EBIs between PY1 and PY2 .001
  −1 or −2 14 1.5 0.3–6.4 .622
  0 78 1.0 Referent
  +1 32 5.3 1.9–14.9 .002
  +2 to +4 32 7.1 2.2–23.1 .001
 No. of enhanced EBIs implemented during PY2 .040
  0 27 1.0 Referent
  1 or 2 71 4.1 1.4–12.0 .012
  3 or 4 58 3.5 1.0–11.7 .046
Control variable
 PY1 CRC screening rate .020
  <25% 32 5.1 1.2–22.9 .032
  25% to <35% 33 4.8 1.3–18.0 .022
  35% to <45% 35 1.5 0.4–5.4 .565
  45% to <55% 34 1.4 0.3–5.5 .665
  >55% 22 1.0 Referent

Abbreviations: CI, confidence interval; CRC, colorectal cancer; EBI, evidence-based intervention; PY1, program year 1; PY2, program year 2; Q4, highest quartile.

The final logistic model also included clinic size as a control variable, which was not significant